Focus Stocks
Trading Idea: - Is Pfizer close to Resistance?
Published on Wednesday, 09 May 2012 09:40 Written by TradersHuddle Wire
New York, May 9th (TradersHuddle.com) - Shares of Pfizer, Inc. (NYSE:PFE) are trading very close to calculated resistance at $23.30. The stock ended the trading session at just $22.42, which is near levels that make it difficult to buy or start a position.
Pfizer Inc. (NYSE:PFE), the global pharmaceutical company that develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription and non-prescription pharmaceuticals, and animal health products such as anti-infective medicines and vaccines. Some of Pfizer blockbuster drugs are Celebrex for arthritis pain, and inflammation and acute pain, Viagra for erectile dysfunction, and Lipitor for elevated cholesterol levels in the blood. The company was founded in 1849 and is headquartered in New York, NY.
Pfizer's stock range is defined by its calculated support defined at $20.80 and by the resistance level at $23.30; the stock is clearly over-extended from support, making it harder for participants to establish fresh longs.
Traders don't have a clear entry point for Pfizer. However, as the stock pulls back towards $20.80 it will definitely provide a reference point to establish a trade. On the other hand, if the stock breaks above its resistance level at $23.30 then traders will get an opportunity to enter the stock as it moves to a higher range.
Related Articles
- Pfizer Is Close to its 50 Day Moving Average
- TradersHuddle Dow's Update, In focus:PFE, HD, JPM, MSFT, CSCO
- Key Levels for Pfizer
- Close to the 50 Day Moving Average: Pfizer
- Trading Idea: Is Pfizer close to Support?
- Critical Alerts For Pfizer, CBS, International Paper, Youku.com, and InterMune Released By InvestorsObserver
- Top Performing Dow Component: Pfizer
- Will Pfizer recover?
- Trading Idea: Is Pfizer close to Support?
- Accelrys and Pfizer Extend Agreement for Global Deployment of Scientific Innovation Lifecycle Management Software
Related Partner Headlines
- Dow Today: Pfizer (PFE) Higher - TheStreet.com
- Pfizer Inc (PFE): Today's Featured Drugs Laggard - TheStreet.com
- UPDATE: Jefferies & Company Reiterates Buy Rating, Lowers PT on Pfizer - Benzinga
- Pfizer Inc Stock Buy Recommendation Reiterated (PFE) - TheStreet.com
- Pfizer Stock To Go Ex-dividend Tomorrow (PFE) - TheStreet.com
- Pfizer's Third Quarter Earnings Report - Investopedia
- Pfizer Inc (PFE): Today's Featured Drugs Laggard - TheStreet.com
- Pfizer Inc (PFE): Today's Featured Drugs Laggard - TheStreet.com
- Pfizer Inc Stock Buy Recommendation Reiterated (PFE) - TheStreet.com
- Pfizer Announces Top-line Results From Phase 3 Trial Of INLYTA - Benzinga
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,232.89 Trade time:10:40AM EDT Value change:▼74.28 (-0.49%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,643.36 Trade time:10:40AM EDT Value change:▼11.99 (-0.72%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,448.55 Trade time:10:40AM EDT Value change:▼14.75 (-0.43%)In The Wires
-
General Mills Will Web Cast Its Presentation At The Citi 2013 Global Consumer Conference -
First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection -
Foraco International SA shareholders meeting declared a dividend of CDN$ 0.055 -
Privileged World Travel Club, Inc. Set to acquire controlling interest in Travel Marvelz of San Diego -
Newcrest Mining Limited - Statement from Newcrest regarding NSW Land and Environment Court decision of 17 May 2013 -
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of SoundBite Communications, Inc. in Connection with the Sale of the Company to Genesys -
AT&T 4G LTE Takes Top Spot In Washington, DC In 2013 PCWorld/TechHive Speed Tests -
Cancer Network Introduces Three New Features








